Minnesota accuses insulin makers of deceptive drug pricing

(Reuters) - Minnesota’s attorney general on Tuesday filed a lawsuit accusing drug manufacturers Sanofi SA, Novo Nordisk and Eli Lilly and Co of deceptively raising prices for insulin.

The logo and ticker for Eli Lilly and Co. are displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 18, 2018. REUTERS/Brendan McDermid

In a lawsuit filed in federal court in Trenton, New Jersey, Minnesota Attorney General Lori Swanson took aim at the companies after the list price for some insulin products more than tripled since 2002.

Reporting by Nate Raymond in Boston; Editing by David Gregorio

Our Standards:The Thomson Reuters Trust Principles.

Source link

Ads by Revcontent
« Previous article Goldman Sachs will slow consumer loan growth if market falters
Next article » Trump says Saudi prince denies knowing what happened at consulate